Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

MLA

Jackman D, et al. “Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer.” Journal of Clinical Oncology, vol. 28, no. 2, Jan. 2010, pp. 357–60. EBSCOhost, https://doi.org/10.1200/JCO.2009.24.7049.

APA

Jackman D, Pao W, Riely GJ, Engelman JA, Kris MG, Jänne PA, Lynch T, Johnson BE, Miller VA, Jackman, D., Pao, W., Riely, G. J., Engelman, J. A., Kris, M. G., Jänne, P. A., Lynch, T., Johnson, B. E., & Miller, V. A. (2010). Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Journal of Clinical Oncology, 28(2), 357–360. https://doi.org/10.1200/JCO.2009.24.7049

Chicago

Jackman D, Pao W, Riely GJ, Engelman JA, Kris MG, Jänne PA, Lynch T, et al. 2010. “Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer.” Journal of Clinical Oncology 28 (2): 357–60. doi:10.1200/JCO.2009.24.7049.